₹1,300.00
Composition: Telmisartan 40 mg + Cilnidipine 10 mg + Metoprolol Succinate (ER) 50 mg
TELECOP TRIO 50 is a triple-combination antihypertensive tablet formulated to provide comprehensive blood pressure management. The combination helps reduce blood pressure through complementary mechanisms, supports cardiovascular protection, and improves patient compliance with a convenient once-daily regimen.
Benefits:
Triple-action blood pressure control
Helps reduce systolic and diastolic BP
Supports cardiovascular protection
Helps reduce heart rate and cardiac workload
Once-daily extended-release convenience
Improves patient compliance with single-tablet therapy
Dosage: As directed by the physician.
Storage: Store in a cool, dry place away from direct sunlight.
Composition: Telmisartan 40 mg + Cilnidipine 10 mg + Metoprolol Succinate (ER) 50 mg
TELECOP TRIO 50 combines Telmisartan 40 mg, Cilnidipine 10 mg, and Metoprolol Succinate (ER) 50 mg in a single tablet designed for effective management of hypertension in patients who require combination therapy.
The formulation provides a comprehensive approach to blood pressure control:
Telmisartan helps relax blood vessels by blocking angiotensin II activity.
Cilnidipine supports blood vessel relaxation and helps reduce peripheral resistance.
Metoprolol Succinate (ER) helps control heart rate and reduce cardiac workload through extended-release action.
Key Advantages
Synergistic BP reduction through multiple mechanisms
Convenient once-daily dosing
Supports long-term hypertension management
May improve adherence compared with multiple separate tablets
Suitable for patients requiring triple-drug antihypertensive therapy under medical supervision
Indications
Essential hypertension
Uncontrolled hypertension requiring combination therapy
Patients at elevated cardiovascular risk, as advised by the physician
Directions for Use
Take once daily or as directed by the physician.
Swallow the tablet whole with water.
Do not crush or chew the extended-release tablet.
Precautions
Use only under medical supervision.
Inform the physician about existing heart, kidney, or liver conditions.
Regular blood pressure monitoring is recommended.